In addition to some routinely applied tumor markers, such as α-Fetoprotein (AFP), CEA, CA19-9 and carbohydrate antigen 72-4 (CA72-4), there are still many other tumor markers used in different hospitals [16]. This evidence concerns the gene CEACAM5 and neoplasm.